Understanding how liver injury affects blood flow in portal hypertension
A Molecular Approach to the Pathogenesis of Portal Hypertension
This study is looking into how liver damage affects blood flow in people with portal hypertension, focusing on certain proteins that help control blood flow, so we can better understand the condition and find new ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11031981 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind portal hypertension, particularly focusing on how liver injury disrupts the balance of blood flow regulators. The team will explore the role of specific proteins that affect nitric oxide production, which is crucial for maintaining proper blood flow in the liver. By examining the interactions between these proteins and their impact on liver cells, the research aims to uncover new insights into the pathogenesis of this condition. Patients may benefit from a better understanding of how portal hypertension develops and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with portal hypertension or those with liver injury-related conditions.
Not a fit: Patients without liver disease or those not experiencing portal hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve blood flow and reduce complications associated with portal hypertension.
How similar studies have performed: Previous research has shown promising results in understanding the molecular pathways involved in liver diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Rockey, Don C. — Medical University of South Carolina
- Study coordinator: Rockey, Don C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.